Ambit Biosciences Corp
Change company Symbol lookup
Select an option...
AMBI Ambit Biosciences Corp
AXDX Accelerate Diagnostics Inc
GWR Genesee & Wyoming Inc
DNB Dun & Bradstreet Corp
BAC Bank of America Corp
QCBMIX CREF Bond Market Account Class R3
WIN Windstream Holdings Inc
RYI Ryerson Holding Corp
ACIA Acacia Communications, Inc.
SENS Senseonics Holdings Inc
Go

Health Care : Biotechnology | Company profile

Ambit Biosciences Corporation is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company’s lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company’s second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company’s third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

Closing Price
--
Day's Change
--
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
--
  • Prev Close
    --
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    --
  • Last (time)
    --
  • Last (size)
    --
  • 52-Wk Range
    -- - --
    LowHigh
    unavailable
  • (-- - --)
    --
  • 93.0%
  • Market Cap
    --
  • Shares Outstanding
    --
  • --
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • --
  • (% of float 10/31/14)
    0.49

Latest News

Today's News, May 25, 2016
4:44 pm ET
MarketWatch
4:43 pm ET
MarketWatch
4:40 pm ET
Market Wire
4:40 pm ET
BusinessWire
4:39 pm ET
BusinessWire
4:39 pm ET
PR Newswire
4:39 pm ET
PR Newswire
4:37 pm ET
MarketWatch
4:36 pm ET
BusinessWire
4:35 pm ET
PR Newswire
4:34 pm ET
PR Newswire
4:34 pm ET
PR Newswire
4:33 pm ET
Globe Newswire
4:33 pm ET
BusinessWire
4:33 pm ET
PR Newswire
4:33 pm ET
PR Newswire
4:33 pm ET
PR Newswire
4:31 pm ET
PR Newswire
4:30 pm ET
Globe Newswire
4:30 pm ET
Market Wire
4:30 pm ET
Globe Newswire
4:30 pm ET
Globe Newswire
4:30 pm ET
Globe Newswire
4:30 pm ET
PR Newswire
4:30 pm ET
PR Newswire
4:30 pm ET
BusinessWire
4:30 pm ET
BusinessWire
4:30 pm ET
PR Newswire
4:30 pm ET
PR Newswire
4:30 pm ET
BusinessWire
4:30 pm ET
PR Newswire
4:30 pm ET
BusinessWire
4:30 pm ET
BusinessWire
4:30 pm ET
PR Newswire
4:29 pm ET
BusinessWire
Go to all current & historical news

Events

There are no calendar events for AMBI

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.